Carregant...
Pharmacokinetics Modeling of Exogenous Glucagon in Type 1 Diabetes Mellitus Patients
BACKGROUND: Insulin-induced hypoglycemia is as a critical barrier in the treatment of type 1 diabetes mellitus patients and may lead to unconsciousness, brain damage, or even death. Clinically, glucagon is used as a rescue drug to treat severe hypoglycemic episodes. More recently, in a bihormonal cl...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Mary Ann Liebert, Inc.
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3818836/ https://ncbi.nlm.nih.gov/pubmed/23978267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2013.0150 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|